47.73.Z - Retail sale of pharmaceutical products
46.46.Z - Wholesale trade of pharmaceutical and medical products
46.90.Z - Non-specialized wholesale trade
47.19.Z - Retail trade
47.74.Z - Retail sale of medical and orthopedic products
47.75.Z - Retail sale of cosmetics and toiletries
47.78.Z - Retail sale of other new products
47.91.Z - Intermediary retail sale, non-specialized
47.99.Z - Retail trade
58.19.Z - Other publishing activities, excluding software publishing
2021 | 2022 | 2023 | ||
---|---|---|---|---|
M PLN | M PLN | M PLN | % | |
Profit (loss) on sale | 0,5 | 0,2 | 0,1 | -40,9 |
Gross profit (loss) | 0,1 | 0,1 | 0,1 | -49,7 |
EBITDA | 0,2 | 0,2 | 0,1 | -55,9 |
Short time liabilities | 0,4 | 0,4 | 0,4 | 2,9 |
Other operating costs | 0,4 | 0 | 0 | 37,5 |
Equity capital | 0,3 | 0,4 | 0,5 | 20,3 |
Operating profit (EBIT) | 0,2 | 0,2 | 0,1 | -53 |
Assets | 0,7 | 0,8 | 0,9 | 11,4 |
Net profit (loss) | 0,1 | 0,1 | 0,1 | -50,5 |
Cash | 0,2 | 0,2 | 0,2 | -1,8 |
Net income from sale | 5,1 | 5,4 | 5,2 | -4 |
Liabilities and provisions for liabilities | 0,4 | 0,4 | 0,4 | 2,9 |
Working assets | 0,7 | 0,8 | 0,9 | 11,1 |
Other income costs | 0 | 0 | 0 | -89,9 |
Depreciation | 0 | 0 | 0 | -100 |
% | % | % | p.p. | |
Profitability of capital | 17,6 | 28,8 | 11,8 | -17 |
Equity capital to total assets | 46,6 | 49 | 52,9 | 3,9 |
Gross profit margin | 1,8 | 2,6 | 1,4 | -1,2 |
EBITDA Margin | 3,7 | 3 | 1,4 | -1,6 |
Days | Days | Days | Days | |
Short term commitment turnover cycle | 26 | 29 | 31 | 2 |
Current financial liquidity indicator | 1.8741064071655273 | 1.9608725309371948 | 2.1161556243896484 | 0,1 |
Net dept to EBITDA | -1.0916993618011475 | -1.460895299911499 | -3.250924825668335 | -1,8 |
Opinie dotyczące usług, produktów oraz działalności firmy nie są weryfikowane